Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigid S Boland

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2024
Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn's Disease: Secondary Analysis of the PYRAMID RegistryDhruv Ahuja, Jiyu Luo, Yuchen Qi, et al.
Journal of Crohn'S & Colitis|September 11, 2020
Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment EndpointSushrut Jangi, Ariela K Holmer, Parambir S Dulai, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2020
Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healingSushrut Jangi, Hyuk Yoon, Parambir S Dulai, et al.
Gastroenterology|June 26, 2020
Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-AnalysisHyuk Yoon, Sushrut Jangi, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|June 15, 2022
A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's DiseaseAriela K Holmer, Brigid S Boland, Siddharth Singh, et al.
Biological Psychiatry|April 12, 2005
Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonistMargaret A Fonder, Kristi A Sacco, Angelo Termine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2024
Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF AntagonistsHan Hee Lee, Virginia Solitano, Sujay Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2025
Prevalence and Impact of Social Risk in Patients With Inflammatory Bowel Diseases: National Estimates from the United StatesSeo Hyun Kim, Yuchen Qi, Matthew P Banegas, et al.
The American Journal of Gastroenterology|March 12, 2025
IL-23p19 Antagonists vs Ustekinumab for Treatment of Crohn's Disease: A Meta-Analysis of Randomized Controlled TrialsClaudia Dziegielewski, Yuhong Yuan, Christopher Ma, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2020
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's diseaseEdward Yang, Nicola Panaccione, Natalie Whitmire, et al.
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 12, 2024
Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn's Disease: Secondary Analysis of the PYRAMID RegistryDhruv Ahuja, Jiyu Luo, Yuchen Qi, et al.
Journal of Crohn'S & Colitis|September 11, 2020
Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment EndpointSushrut Jangi, Ariela K Holmer, Parambir S Dulai, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2020
Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healingSushrut Jangi, Hyuk Yoon, Parambir S Dulai, et al.
Gastroenterology|June 26, 2020
Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-AnalysisHyuk Yoon, Sushrut Jangi, Parambir S Dulai, et al.
Inflammatory Bowel Diseases|June 15, 2022
A Serum Biomarker Panel Can Accurately Identify Mucosal Ulcers in Patients With Crohn's DiseaseAriela K Holmer, Brigid S Boland, Siddharth Singh, et al.
Biological Psychiatry|April 12, 2005
Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonistMargaret A Fonder, Kristi A Sacco, Angelo Termine, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 28, 2024
Differential Efficacy of Advanced Therapies in Inducing Remission in Ulcerative Colitis Based on Prior Exposure to TNF AntagonistsHan Hee Lee, Virginia Solitano, Sujay Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2025
Prevalence and Impact of Social Risk in Patients With Inflammatory Bowel Diseases: National Estimates from the United StatesSeo Hyun Kim, Yuchen Qi, Matthew P Banegas, et al.
The American Journal of Gastroenterology|March 12, 2025
IL-23p19 Antagonists vs Ustekinumab for Treatment of Crohn's Disease: A Meta-Analysis of Randomized Controlled TrialsClaudia Dziegielewski, Yuhong Yuan, Christopher Ma, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2020
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's diseaseEdward Yang, Nicola Panaccione, Natalie Whitmire, et al.
Pageof 10